SCHEMBL26885235

SCHEMBL26885235

O=C(Nc1ccccc1)c1ccc(-c2ccc(C(=O)Nc3ccc4ccccc4c3)cn2)nc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.63
▸ NPC1 O15118 12/20 0.61
▸ RAB9A P51151 12/20 0.61
▸ MEN1 O00255 5/20 0.61
▸ KMT2A Q03164 5/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ KDM4E B2RXH2 3/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ MAPT P10636 2/20 0.57
▸ P4HTM Q9NXG6 2/20 0.56
▸ DEGS1 O15121 1/20 0.56
▸ PTPN2 P17706 1/20 0.53
▸ PTPN1 P18031 1/20 0.53
▸ NR1H4 Q96RI1 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ GPR27 Q9NS67 1/20 0.53
▸ PLAU P00749 1/20 0.52
▸ CASP3 P42574 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26885198 0.96 NPC1 (0.66) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885195 0.92 TRPV1 (0.68) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885196 0.92 TRPV1 (0.68) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885203 0.92 DEGS1 (0.60) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885210 0.91 NPC1 (0.60) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885211 0.88 TRPV1 (0.66) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885205 0.88 TRPV1 (0.66) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885199 0.88 TRPV1 (0.69) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26885218 0.85 DEGS1 (0.64) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL26889461 0.84 DEGS1 (0.57) TRPV1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF ACE2, ACE, SARS1 TRPV1 1641/4885NPC1 72/4885RAB9A 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback